// App-Quantinova.ai

TCT-791 : Impact of Clinical Judgement on Risk Stratification of Patients at High Risk for TAVR: A BRAVO-3 Subgroup Analysis

Researchers

Presenter

  • Matias Yudi

Principal Investigators

  • Roxana Mehran

  • Thierry Lefevre

  • John Webb

  • Eric Van Belle

  • Annapoorna Kini

  • Samin Sharma

  • David Hildick-Smith

  • Rainer Hambrecht

  • Julian Widder

  • Sabato Sorrentino

  • Serdar Farhan

  • Samantha Sartori

  • Jaya Chandrasekhar

  • Prodromos Anthopoulos

  • Christian Hengstenberg

  • George Dangas

Medical Centers

  • Deutsches Herzzentrum Munchen, Munich, Germany

  • Centre for Heart Valve Innovation, St. Paul's and Vancouver General Hospital, Vancouver, British Columbia, Canada

  • Klinikum Links der Weser, Bremen, Germany

  • Insititut Coeur Poumon - Centre Hospitalier Regional, Lille Cedex, France

  • Icahn School of Medicine at Mount Sinai, New York, New York, United States

  • Royal Sussex County Hospital, Brighton, United Kingdom

  • Ramsay Générale de Santé, Institut Cardiovasculaire Paris-Sud, Massy, France

  • Mount Sinai Health System, New York, New York, United States

  • Zena and Michael A. Wiener Cardiovascular Institute, Mount Sinai Hospital, New York, New York, United States

  • Hannover Medical School, Hannover, Germany

Locations

  • Germany

  • United States

  • France

  • United Kingdom

  • Switzerland

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Randomized

  • Controlled

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved